JRCT ID: jRCT1080224632
Registered date:11/04/2019
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 27/05/2019 |
Target sample size | 70 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | other |
---|---|
Secondary Outcome | other |
Key inclusion & exclusion criteria
Age minimum | >= 40age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03957577,JapicCTI-194704 |
Contact
Public contact | |
Name | |
Address | Akasaka Intercity AIR, 1-8-1 Akasaka, Minato-ku, Tokyo, Japan |
Telephone | +81-120-561-007 |
jp.gskjrct@gsk.com | |
Affiliation | GlaxoSmithKline K.K. |
Scientific contact | |
Name | |
Address | Akasaka Intercity AIR, 1-8-1 Akasaka, Minato-ku, Tokyo, Japan |
Telephone | +81-120-561-007 |
jp.gskjrct@gsk.com | |
Affiliation | GlaxoSmithKline K.K. |